As a leader in healthcare, Bayer provides innovative The Bayer brand stands for trust, reliability and quality throughout the world. Phone: +49 214 30 1, Mllerstrae 178 A cookie is a small text file that a web server stores in browser software. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. NextPoint Therapeutics, a provider of precision immuno-oncology, has raised raised $80 million in Series B financing. Compact, Group These materials do not constitute or form a part of any offer or Similar to PD-L1, the tumor antigen HHLA2 is a member of the B7 receptor family, is highly expressed on certain hard-to-treat cancers, and drives avoidance of detection from the immune system. INFORMATION FROM CHILDREN UNDER 13 YEARS OF AGE. Third parties that help us administer and manage our Services, including third parties that help us manage our communications, complete transactions, assist with our information technology and security programs, our lawyers, accountants, auditors, or regulatory bodies or other third parties as may be required by law. Our Site may use the following technologies to implement cookies and pixels: If you do not wish to receive any interest-based advertising, you can deactivate Googles use of cookies for these purposes by going tohttps://www.google.com/settings/ads. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. This website is intended to provide information to an international audience outside the USA and UK. made on the basis of the securities prospectus. Founded by MPM Capital, NextPoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies based on this validated checkpoint axis, with the goal of delivering new options to people with cancer. and may not be offered or sold in the United States, except pursuant to an exemption from, or in a Marketing & Sales, Group and Social Needs, Bayer and They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. life. Dr. Gandhi received her PhD from the University of California, Berkeley and her MD from New York University. Digital in Warsaw, Bayer Bayer is an innovation company with a more than 150-year history. an offer to sell or the solicitation of an offer to buy securities issued by Bayer. NextPoints outstanding team of scientists who have characterized the HHLA2 pathway along with experienced drug developers in the management team makes for the ideal chemistry to usher these novel immuno-oncology programs into the clinic.. Personal Information does not include publicly available information, information that is de-identified, aggregated information, or any other information outside the scope of the California Consumer Privacy Act of 2018 (CCPA). 10-01-2023 Print. NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. These electronic materials are thus extremely vulnerable to unauthorized distribution and copyright infringement. Transmit materials that contain any viruses, Trojan horses, worms, time bombs, cancelbots or other computer-programming routines that are intended to damage, detrimentally interfere with, surreptitiously intercept or expropriate any system, data or personal information. As described in detail below, we may collect certain Personal Data from or about you in connection with your use of, or your submissions to, the Site. Vote, Voting Strategy, Bio Revolution NextPoint Therapeutics, founded and funded by MPM Capital, has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class #immunotherapies based on a novel,. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. If we become aware that an individual under 13 years has provided us with Personal Data without parental consent, we will take steps to remove the data as permitted by law. Counterfeits, Recognizing She completed postgraduate training at Massachusetts General Hospital and at Dana-Farber Cancer Institute in Boston. Use the Website to artificially generate traffic or page links to a website or for any other purpose not expressly allowed under these Terms. CAMBRIDGE, Mass. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today the appointment of Leena Gandhi, MD, PhD, as Chief Medical Officer (CMO).. As CMO, Dr. Gandhi will oversee the clinical development of NextPoint's precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Cambridge, MA / Leverkusen, Germany, January 10, 2023 NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. Forward-Looking StatementsThis release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Interview, Check jurisdictions, only certain categories of person may be allowed to view such materials. Germany Global Product Strategy, Position Trends, Rise solutions Prospectus Directive. About NextPoint Therapeutics. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and Sanofi Ventures, the strategic venture capital arm for Sanofi. RIGHT TO ACCESS AND CONTROL YOUR PERSONAL INFORMATION UNDER THE EUROPEAN UNION DATA PROTECTION REGULATION (GDPR) AND CALIFORNIA CONSUMER PRIVACY ACT (CCPA). offering or an invitation to the public in connection with any offer within the meaning of offer of the securities in any jurisdiction. 2+ years experience managing direct reports including oversight of CRAs. Your computer and mobile devices when you visit our Site. Existing investors that took part in the financing include MPM Capital Management, Binney Street Capital/Dana-Farber Cancer Institute and NextPoint founder Gordon Freeman, PhD. Please note that if you do not provide consent, if you withdraw your consent or object to processing, or if you choose not to provide certain Personal Data, we may be unable to provide you some or all of the Site. Team, Our About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. application, Your Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. They are all working on potentially breakthrough technologies to overcome some specific challenges such as, e.g., developing a sustainable protein supply, reducing the environmental impact of agriculture, preventing or curing cancer, and others. About NextPoint Therapeutics NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. For more information, go to www.bayer.com. Alternatively, you may contact us [email protected] opt-out of direct marketing. Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. The company and its founders have shown in preclinical models and with analysis of existing clinical datasets that the HHLA2 pathway is an important tumor-suppressive mechanism in many patients, NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. Development Policy, Corporate (DE), Bayer & Rewards, Values US precision immuno-oncology biotech NextPoint Therapeutics has raised $80 million in a Series B financing co-led by Leaps by Bayer, the impact investment arm of Germany's Bayer (BAYN: DE), and Sanofi Ventures, the strategic venture capital arm for French drugmaker Sanofi (Euronext: SAN). This time around, we note that NextPoint Therapeutics hired Leena Gandhi as chief medical officer. Effective Date. As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. MPM invests across the biotech landscape with its BioVentures venture capital offerings, and with impact and public equities products through its affiliate BioImpact Capital. The Site provides a venue to obtain information about NextPoint, our activities, and products we may offer. Strong knowledge of pharmaceutical regulations e.g., GCP/ICH, GLP, GDPR, etc. For more information about our privacy practices, if you have questions, or if you would like to make a complaint, please contact us by e-mail [email protected] by mail at the following address: NextPoint Therapeutics, Inc.450 Kendall StreetCambridge, MA 02142. Features YOU EXPRESSLY AGREE THAT USE OF THE WEBSITE AND RELATED CONTENT IS AT YOUR SOLE RISK. Janakiram M, Chinai JM, Fineberg S, et al. In other Drs. These factors include those discussed in Bayers public reports which are available on the Bayer website at, . Rights Policy, Responsible Use the Website to test or reverse engineer the Website in order to find limitations, vulnerabilities or to evade filtering capabilities. Japan or in any other jurisdiction in which such offer or solicitation is not authorized or to any The AP news staff was not involved in its creation. designed to prevent, alleviate and treat diseases. Stockholders' Meeting, Notice Sustainable Development Goals, Position and Life in balance, Healthy For purposes of this Privacy Notice, Personal Data means any information relating to an identified or identifiable natural person. State by any measure implementing the Prospectus Directive in that Relevant Member State, and the solicitation of an offer to buy securities issued by Bayer. Report, Quarterly Sustainable Beef Production, Responsible Business in the Pipeline, Trends in Science, Our Protection Products & Seeds, Supplier Kaiser-Wilhelm-Allee 1 You can use our locations menu to find Bayer country websites and At the same time, the Group aims to increase its earning power and create value through innovation and growth. NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-led by Leaps by Bayer, the . Press release content from Business Wire. 10+ years of pharmaceutical or biotechnology industry experience or mix of industry and academic experience in oncology or cancer immunotherapy with an emphasis on translational research, clinical biomarkers, and monoclonal antibodies, Proven track record of transitioning biomarkers from the bench to the clinic, Strong knowledge of immuno-oncology and associated biomarker approaches, Technical expertise in IHC, RNAscope, flow cytometry, genetics (including ctDNA), RNA-Seq, NanoString, qPCR and ELISAs, Proven success with filing INDs and supporting clinical trials, Competency with bioinformatic datasets and experience collaborating with bioinformaticians to analyze publicly available datasets, Excellent communication and interpersonal skills, personal integrity, professional manner, and ability to gain respect and develop good working relationships with cross functional personnel at all levels, Ability to balance multiple stakeholders and projects simultaneously, and able to operate with high accountability and under tight deadlines, Forward looking thinker, who actively seeks opportunities and proposes solutions with strong decision-making capability, A collaborator who communicates in an open, clear, complete, timely and consistent manner who listens effectively and invites response and discussion, Direct and run clinical operations and clinical trial launch activities for clinical programs, Manage clinical research organizations, clinical and testing lab vendors, Establish clinical operations infrastructure across the organization, Maintain relationships with Sites and KOLs, Represent NextPoint at Scientific and Investigator Meetings, Stay apprised of current trends in clinical trials research and regulatory landscape, Take responsibility for launch and day-to-day operational management of clinical trials including study sites, Participate in Clinical Vendor Governance and Safety Review Committee Meetings, Design and perform ligand binding assays in multi-well formats to analyze novel antibody therapeutics, Develop and execute functional assays involving primary human immune cells, mammalian cell culture, and multi-color flow cytometry to screen novel antibody therapeutics in an immune-oncology setting, Work independently to design and conduct experiments, analyze, interpret, and communicate data in team meetings and to leadership, Support the laboratory organization and operations by maintaining lab equipment and managing reagent and supply inventories, Bachelors degree in cell/molecular biology, immunology, or cancer biology or equivalent field, 2 + years hands-on experience in drug discovery research preferably in an industry setting, Experience with cell-based functional immune assays such as MLR, immune cell activity assays, and cytokine release assays, Experience with multiparameter flow cytometry, Hands on experience with murine tumor models preferred, Excellent verbal and written communication skills with a demonstrated ability to work collaboratively and thrive in a team environment, Excellent interpersonal skills and willingness to learn a variety of new techniques and technologies; flexibility to adapt to rapidly changing priorities and deadlines. Management, Supervisory If you are not permitted to view materials on this webpage or are in any doubt as to whether you are Board, Document Download NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together Governance, Board of land, water and energy. Subject to applicable law, the purposes for which we use and process Personal Data, and the legal basis for such processing, are set forth below. Consensus, Return Bayer Global Innovations, Redefining Expertise, Our
Who Owns Maverik Gas Stations, Copper Hills Bantam Basketball, Johnson Middle School Dress Code, Articles N